APAC Tumor Ablation Market - Industry Trends and Forecast to 2030

List of Tables

Asia-Pacific tumor ablation market is expected to reach USD 977.75 Million by 2030 from USD 390.27 Million in 2022, growing at a CAGR of 12.2% during the forecast period of 2023 to 2030.

Market Segmentation:

Asia-Pacific Tumor Ablation Market, By Type (Thermal Ablation, and Chemical Ablation), Types of Treatment (Percutaneous, Laparoscopic, and Surgical), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Liver Cancer, Kidney Cancer, Bone Cancer, and Others), End Users (Hospitals, Oncology Centers, and Others), Distribution Channel (Direct Tender, and Retail Sales), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia ,Philippines ,Vietnam, New Zealand, and Rest of Asia-Pacific) -Industry Trends and Forecast to 2030.

Overview of Asia-Pacific Tumor Ablation Market Dynamics :

Driver
Increasing awareness and education regarding tumor ablation
Restrain
Technical challenges in targeting the tumor
Opportunity
Strategic initiatives by major market players

Market Players:

Some of the key players operating in the Asia-Pacific tumor ablation market are:

Boston Scientific Corporation
Medtronic
Olympus
Stryker
Biotronik
AngioDynamics
Bioventus LLC.
BVM Medical Limited
EDAP TMS
Ethicon, Inc.
HealthTronics, Inc.
IceCure Medical

1 INTRODUCTION 35

1.1 OBJECTIVES OF THE STUDY 35
1.2 MARKET DEFINITION 35
1.3 OVERVIEW OF THE ASIA PACIFIC TUMOR ABLATION MARKET 35
1.4 CURRENCY AND PRICING 37
1.5 LIMITATIONS 37
1.6 MARKETS COVERED 37

2 MARKET SEGMENTATION 40

2.1 MARKETS COVERED 40
2.2 GEOGRAPHICAL SCOPE 41
2.3 YEARS CONSIDERED FOR THE STUDY 42
2.4 DBMR TRIPOD DATA VALIDATION MODEL 43
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 46
2.6 MULTIVARIATE MODELLING 47
2.7 TYPE SEGMENT LIFELINE CURVE 48
2.8 MARKET END USERS COVERAGE GRID 49
2.9 DBMR MARKET POSITION GRID 50
2.10 VENDOR SHARE ANALYSIS 51
2.11 SECONDARY SOURCES 52
2.12 ASSUMPTIONS 52

3 EXECUTIVE SUMMARY 53

4 PREMIUM INSIGHTS 55

4.1 PESTEL ANALYSIS 56
4.2 PORTER'S FIVE FORCES MODEL 57

5 REGULATORY FRAMEWORK 58

5.1 REGULATORY SCENARIO IN CHINA 58
5.2 REGULATORY SCENARIO IN AUSTRALIA 59

6 MARKET OVERVIEW 60

6.1 DRIVERS 62
- 6.1.1 RISING PREVALENCE OF CANCER ASIA PACIFICLY 62
- 6.1.2 INCREASING INCLINATION OF SURGEONS AND PATIENTS TOWARD MINIMALLY INVASIVE PROCEDURES 62
- 6.1.3 RISING TECHNOLOGICAL ADVANCEMENTS 63
- 6.1.4 INCREASING AWARENESS AND EDUCATION 63
6.2 RESTRAINTS 64
- 6.2.1 REGULATORY HURDLES FOR APPROVAL 64
- 6.2.2 LIMITED CLINICAL EVIDENCE 64
6.3 OPPORTUNITIES 65
- 6.3.1 FAVORABLE REIMBURSEMENT SCENARIO 65
- 6.3.2 STRATEGIC INITIATIVES BY MAJOR MARKET PLAYERS 65
6.4 CHALLENGES 66
- 6.4.1 TECHNICAL CHALLENGES IN TARGETING THE TUMOR 66
- 6.4.2 COMPETITION FROM ALTERNATIVE TREATMENT MODALITIES 66

7 ASIA PACIFIC TUMOR ABLATION MARKET, BY TYPE 67

7.1 OVERVIEW 68
7.2 THERMAL ABLATION 71
- 7.2.1 TUMOR ABLATION SYSTEMS 72
  - 7.2.1.1 RADIOFREQUENCY 73
    - 7.2.1.1.1 BIPOLAR 73
    - 7.2.1.1.2 MULTIPOLAR 73
- 7.2.2 IMAGE GUIDANCE PRODUCTS AND ACCESSORIES 73
  - 7.2.2.1 CT 74
  - 7.2.2.2 MR IMAGING 74
  - 7.2.2.3 FLUOROSCOPY 74
  - 7.2.2.4 OTHERS 74
  - 7.2.2.5 MICROWAVE 74
  - 7.2.2.6 CRYOABLATION 74
  - 7.2.2.7 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) 74
  - 7.2.2.8 LASER 74
7.3 CHEMICAL ABLATION 74
- 7.3.1 ETHANOL 75
- 7.3.2 ACETIC ACID 75

8 ASIA PACIFIC TUMOR ABLATION MARKET, BY TYPES OF TREATMENT 76

8.1 OVERVIEW 77
8.2 PERCUTANEOUS 80
- 8.2.1 BREAST CANCER 81
- 8.2.2 LUNG CANCER 81
- 8.2.3 PROSTATE CANCER 81
- 8.2.4 LIVER CANCER 81
- 8.2.5 KIDNEY CANCER 81
- 8.2.6 OTHER CANCERS 81
8.3 LAPAROSCOPY 81
- 8.3.1 BREAST CANCER 82
- 8.3.2 LUNG CANCER 82
- 8.3.3 PROSTATE CANCER 82
- 8.3.4 LIVER CANCER 82
- 8.3.5 KIDNEY CANCER 83
- 8.3.6 OTHER CANCERS 83
8.4 SURGICAL 83
- 8.4.1 BREAST CANCER 84
- 8.4.2 LUNG CANCER 84
- 8.4.3 PROSTATE CANCER 84
- 8.4.4 LIVER CANCER 84
- 8.4.5 KIDNEY CANCER 84
- 8.4.6 OTHER CANCERS 84

9 ASIA PACIFIC TUMOR ABLATION MARKET, BY CANCER TYPE 85

9.1 OVERVIEW 86
9.2 BREAST CANCER 89
9.3 LUNG CANCER 89
9.4 PROSTATE CANCER 90
9.5 LIVER CANCER 91
9.6 KIDNEY CANCER 92
9.7 BONE CANCER 93
9.8 OTHERS 94

10 ASIA PACIFIC TUMOR ABLATION MARKET, BY END USERS 95

10.1 OVERVIEW 96
10.2 HOSPITALS 99
10.3 ONCOLOGY CENTERS 99
10.4 OTHERS 100

11 ASIA PACIFIC TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL 101

11.1 OVERVIEW 102
11.2 DIRECT TENDER 105
11.3 RETAIL SALES 105

12 ASIA PACIFIC TUMOR ABLATION MARKET, BY REGION 107

12.1 ASIA PACIFIC 108
- 12.1.1 CHINA 118
- 12.1.2 JAPAN 123
- 12.1.3 INDIA 128
- 12.1.4 AUSTRALIA 133
- 12.1.5 SOUTH KOREA 138
- 12.1.6 INDONESIA 143
- 12.1.7 PHILIPPINES 148
- 12.1.8 THAILAND 153
- 12.1.9 MALAYSIA 158
- 12.1.10 SINGAPORE 163
- 12.1.11 REST OF ASIA-PACIFIC 168

13 ASIA PACIFIC TUMOR ABLATION MARKET, COMPANY LANDSCAPE 169

13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 169

14 SWOT ANALYSIS 170

15 COMPANY PROFILE 171

15.1 BOSTON SCIENTIFIC CORPORATION 171
- 15.1.1 COMPANY SNAPSHOT 171
- 15.1.2 REVENUE ANALYSIS 171
- 15.1.3 COMPANY SHARE ANALYSIS 172
- 15.1.4 PRODUCT PORTFOLIO 172
- 15.1.5 RECENT DEVELOPMENT 172
15.2 MEDTRONIC 173
- 15.2.1 COMPANY SNAPSHOT 173
- 15.2.2 REVENUE ANALYSIS 173
- 15.2.3 COMPANY SHARE ANALYSIS 174
- 15.2.4 PRODUCT PORTFOLIO 174
- 15.2.5 RECENT DEVELOPMENT 174
15.3 OLYMPUS 175
- 15.3.1 COMPANY SNAPSHOT 175
- 15.3.2 REVENUE ANALYSIS 175
- 15.3.3 COMPANY SHARE ANALYSIS 176
- 15.3.4 PRODUCT PORTFOLIO 176
- 15.3.5 RECENT DEVELOPMENT 176
15.4 STRYKER 177
- 15.4.1 COMPANY SNAPSHOT 177
- 15.4.2 REVENUE ANALYSIS 177
- 15.4.3 COMPANY SHARE ANALYSIS 178
- 15.4.4 PRODUCT PORTFOLIO 178
- 15.4.5 RECENT DEVELOPMENT 178
15.5 BIOTRONIK 179
- 15.5.1 COMPANY SNAPSHOT 179
- 15.5.2 COMPANY SHARE ANALYSIS 179
- 15.5.3 PRODUCT PORTFOLIO 180
- 15.5.4 RECENT DEVELOPMENT 180
15.6 ANGIODYNAMICS. 181
- 15.6.1 COMPANY SNAPSHOT 181
- 15.6.2 REVENUE ANALYSIS 181
- 15.6.3 PRODUCT PORTFOLIO 182
- 15.6.4 RECENT DEVELOPMENT 182
15.7 BIOVENTUS LLC. 183
- 15.7.1 COMPANY SNAPSHOT 183
- 15.7.2 PRODUCT PORTFOLIO 183
- 15.7.3 RECENT DEVELOPMENT 183
15.8 BVM MEDICAL LIMITED 184
- 15.8.1 COMPANY SNAPSHOT 184
- 15.8.2 PRODUCT PORTFOLIO 184
- 15.8.3 RECENT DEVELOPMENT 184
15.9 EDAP TMS 185
- 15.9.1 COMPANY SNAPSHOT 185
- 15.9.2 REVENUE ANALYSIS 185
- 15.9.3 PRODUCT PORTFOLIO 186
- 15.9.4 RECENT DEVELOPMENT 186
15.10 ETHICON, INC. 187
- 15.10.1 COMPANY SNAPSHOT 187
- 15.10.2 PRODUCT PORTFOLIO 187
- 15.10.3 RECENT DEVELOPMENT 187
15.11 HEALTHTRONICS, INC. 188
- 15.11.1 COMPANY SNAPSHOT 188
- 15.11.2 PRODUCT PORTFOLIO 188
- 15.11.3 RECENT DEVELOPMENT 188
15.12 ICECURE MEDICAL 189
- 15.12.1 COMPANY SNAPSHOT 189
- 15.12.2 REVENUE ANALYSIS 189
- 15.12.3 PRODUCT PORTFOLIO 190
- 15.12.4 RECENT DEVELOPMENT 190
15.13 INSIGHTEC. 191
- 15.13.1 COMPANY SNAPSHOT 191
- 15.13.2 PRODUCT PORTFOLIO 191
- 15.13.3 RECENT DEVELOPMENT 191
15.14 INTEGRA LIFESCIENCES 192
- 15.14.1 COMPANY SNAPSHOT 192
- 15.14.2 REVENUE ANALYSIS 192
- 15.14.3 PRODUCT PORTFOLIO 193
- 15.14.4 RECENT DEVELOPMENT 193
15.15 MERIT MEDICAL SYSTEMS. 194
- 15.15.1 COMPANY SNAPSHOT 194
- 15.15.2 REVENUE ANALYSIS 194
- 15.15.3 PRODUCT PORTFOLIO 195
- 15.15.4 RECENT DEVELOPMENT 195
15.16 SONABLATE CORP. 196
- 15.16.1 COMPANY SNAPSHOT 196
- 15.16.2 PRODUCT PORTFOLIO 196
- 15.16.3 RECENT DEVELOPMENT 196
15.17 TERUMO EUROPE NV 197
- 15.17.1 COMPANY SNAPSHOT 197
- 15.17.2 PRODUCT PORTFOLIO 197
- 15.17.3 RECENT DEVELOPMENT 197

16 QUESTIONNAIRE 198

17 RELATED REPORTS 201

LIST OF TABLES

TABLE 1 ASIA PACIFIC TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 56
TABLE 2 ASIA PACIFIC THERMAL ABLATION IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 57
TABLE 3 ASIA PACIFIC THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 58
TABLE 4 ASIA PACIFIC TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 58
TABLE 5 ASIA PACIFIC RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 59
TABLE 6 ASIA PACIFIC IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 59
TABLE 7 ASIA PACIFIC CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 61
TABLE 8 ASIA PACIFIC CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 61
TABLE 9 ASIA PACIFIC TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 65
TABLE 10 ASIA PACIFIC PERCUTANEOUS IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 66
TABLE 11 ASIA PACIFIC PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 66
TABLE 12 ASIA PACIFIC LAPAROSCOPIC IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 68
TABLE 13 ASIA PACIFIC LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 68
TABLE 14 ASIA PACIFIC SURGICAL IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 69
TABLE 15 ASIA PACIFIC SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 70
TABLE 16 ASIA PACIFIC TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 74
TABLE 17 ASIA PACIFIC BREAST CANCER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 75
TABLE 18 ASIA PACIFIC LUNG CANCER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 76
TABLE 19 ASIA PACIFIC PROSTATE CANCER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 20 ASIA PACIFIC LIVER CANCER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 21 ASIA PACIFIC KIDNEY CANCER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 79
TABLE 22 ASIA PACIFIC BONE CANCER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 80
TABLE 23 ASIA PACIFIC OTHERS IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 80
TABLE 24 ASIA PACIFIC TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 84
TABLE 25 ASIA PACIFIC HOSPITALS IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 85
TABLE 26 ASIA PACIFIC ONCOLOGY CENTERS IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 86
TABLE 27 ASIA PACIFIC OTHERS IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 86
TABLE 28 ASIA PACIFIC TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 90
TABLE 29 ASIA PACIFIC DIRECT TENDER IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 91
TABLE 30 ASIA PACIFIC RETAIL SALES IN TUMOR ABLATION MARKET, BY REGION, 2021-2030 (USD MILLION) 92
TABLE 31 ASIA-PACIFIC TUMOR ABLATION MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 98
TABLE 32 ASIA-PACIFIC TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 98
TABLE 33 ASIA-PACIFIC THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 99
TABLE 34 ASIA-PACIFIC TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 99
TABLE 35 ASIA-PACIFIC RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 99
TABLE 36 ASIA-PACIFIC IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 100
TABLE 37 ASIA-PACIFIC CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 100
TABLE 38 ASIA-PACIFIC TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 100
TABLE 39 ASIA-PACIFIC PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 101
TABLE 40 ASIA-PACIFIC LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 101
TABLE 41 ASIA-PACIFIC SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 102
TABLE 42 ASIA-PACIFIC TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 102
TABLE 43 ASIA-PACIFIC TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 103
TABLE 44 ASIA-PACIFIC TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 103
TABLE 45 CHINA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 104
TABLE 46 CHINA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 104
TABLE 47 CHINA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 104
TABLE 48 CHINA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 105
TABLE 49 CHINA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 105
TABLE 50 CHINA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 105
TABLE 51 CHINA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 106
TABLE 52 CHINA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 106
TABLE 53 CHINA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 107
TABLE 54 CHINA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 107
TABLE 55 CHINA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 108
TABLE 56 CHINA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 108
TABLE 57 CHINA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 108
TABLE 58 JAPAN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 109
TABLE 59 JAPAN THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 109
TABLE 60 JAPAN TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 109
TABLE 61 JAPAN RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 109
TABLE 62 JAPAN IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 110
TABLE 63 JAPAN CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 110
TABLE 64 JAPAN TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 110
TABLE 65 JAPAN PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 111
TABLE 66 JAPAN LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 111
TABLE 67 JAPAN SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 112
TABLE 68 JAPAN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 112
TABLE 69 JAPAN TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 113
TABLE 70 JAPAN TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 113
TABLE 71 INDIA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 114
TABLE 72 INDIA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 114
TABLE 73 INDIA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 114
TABLE 74 INDIA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 115
TABLE 75 INDIA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 115
TABLE 76 INDIA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 115
TABLE 77 INDIA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 116
TABLE 78 INDIA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 116
TABLE 79 INDIA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 117
TABLE 80 INDIA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 117
TABLE 81 INDIA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 118
TABLE 82 INDIA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 118
TABLE 83 INDIA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 118
TABLE 84 AUSTRALIA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 119
TABLE 85 AUSTRALIA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 119
TABLE 86 AUSTRALIA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 119
TABLE 87 AUSTRALIA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 120
TABLE 88 AUSTRALIA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 120
TABLE 89 AUSTRALIA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 120
TABLE 90 AUSTRALIA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 121
TABLE 91 AUSTRALIA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 121
TABLE 92 AUSTRALIA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 122
TABLE 93 AUSTRALIA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 122
TABLE 94 AUSTRALIA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 123
TABLE 95 AUSTRALIA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 123
TABLE 96 AUSTRALIA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 123
TABLE 97 SOUTH KOREA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 124
TABLE 98 SOUTH KOREA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 124
TABLE 99 SOUTH KOREA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 124
TABLE 100 SOUTH KOREA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 125
TABLE 101 SOUTH KOREA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 125
TABLE 102 SOUTH KOREA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 125
TABLE 103 SOUTH KOREA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 126
TABLE 104 SOUTH KOREA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 126
TABLE 105 SOUTH KOREA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 127
TABLE 106 SOUTH KOREA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 127
TABLE 107 SOUTH KOREA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 128
TABLE 108 SOUTH KOREA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 128
TABLE 109 SOUTH KOREA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 128
TABLE 110 INDONESIA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 129
TABLE 111 INDONESIA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 129
TABLE 112 INDONESIA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 129
TABLE 113 INDONESIA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 130
TABLE 114 INDONESIA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 130
TABLE 115 INDONESIA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 130
TABLE 116 INDONESIA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 131
TABLE 117 INDONESIA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 131
TABLE 118 INDONESIA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 132
TABLE 119 INDONESIA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 132
TABLE 120 INDONESIA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 133
TABLE 121 INDONESIA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 133
TABLE 122 INDONESIA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 133
TABLE 123 PHILIPPINES TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 134
TABLE 124 PHILIPPINES THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 134
TABLE 125 PHILIPPINES TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 134
TABLE 126 PHILIPPINES RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 135
TABLE 127 PHILIPPINES IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 135
TABLE 128 PHILIPPINES CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 135
TABLE 129 PHILIPPINES TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 136
TABLE 130 PHILIPPINES PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 136
TABLE 131 PHILIPPINES LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 137
TABLE 132 PHILIPPINES SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 137
TABLE 133 PHILIPPINES TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 138
TABLE 134 PHILIPPINES TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 138
TABLE 135 PHILIPPINES TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 138
TABLE 136 THAILAND TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 139
TABLE 137 THAILAND THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 139
TABLE 138 THAILAND TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 139
TABLE 139 THAILAND RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 140
TABLE 140 THAILAND IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 140
TABLE 141 THAILAND CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 140
TABLE 142 THAILAND TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 141
TABLE 143 THAILAND PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 141
TABLE 144 THAILAND LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 142
TABLE 145 THAILAND SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 142
TABLE 146 THAILAND TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 143
TABLE 147 THAILAND TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 143
TABLE 148 THAILAND TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 143
TABLE 149 MALAYSIA TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 144
TABLE 150 MALAYSIA THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 144
TABLE 151 MALAYSIA TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 144
TABLE 152 MALAYSIA RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 145
TABLE 153 MALAYSIA IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 145
TABLE 154 MALAYSIA CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 145
TABLE 155 MALAYSIA TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 146
TABLE 156 MALAYSIA PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 146
TABLE 157 MALAYSIA LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 147
TABLE 158 MALAYSIA SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 147
TABLE 159 MALAYSIA TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 148
TABLE 160 MALAYSIA TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 148
TABLE 161 MALAYSIA TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 148
TABLE 162 SINGAPORE TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 149
TABLE 163 SINGAPORE THERMAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 149
TABLE 164 SINGAPORE TUMOR ABLATION SYSTEMS IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 149
TABLE 165 SINGAPORE RADIOFREQUENCY IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 150
TABLE 166 SINGAPORE IMAGE GUIDANCE PRODUCTS AND ACCESSORIES IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 150
TABLE 167 SINGAPORE CHEMICAL ABLATION IN TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 150
TABLE 168 SINGAPORE TUMOR ABLATION MARKET, BY TYPES OF TREATMENT, 2021-2030 (USD MILLION) 151
TABLE 169 SINGAPORE PERCUTANEOUS IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 151
TABLE 170 SINGAPORE LAPROSCOPIC IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 152
TABLE 171 SINGAPORE SURGICAL IN TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 152
TABLE 172 SINGAPORE TUMOR ABLATION MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 153
TABLE 173 SINGAPORE TUMOR ABLATION MARKET, BY END USERS, 2021-2030 (USD MILLION) 153
TABLE 174 SINGAPORE TUMOR ABLATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 153
TABLE 175 REST OF ASIA PACIFIC TUMOR ABLATION MARKET, BY TYPE, 2021-2030 (USD MILLION) 154

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC TUMOR ABLATION MARKET: SEGMENTATION 25
FIGURE 2 ASIA PACIFIC TUMOR ABLATION MARKET: DATA TRIANGULATION 28
FIGURE 3 ASIA PACIFIC TUMOR ABLATION MARKET: DROC ANALYSIS 29
FIGURE 4 ASIA PACIFIC TUMOR ABLATION MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 30
FIGURE 5 ASIA PACIFIC TUMOR ABLATION MARKET: COMPANY RESEARCH ANALYSIS 30
FIGURE 6 ASIA PACIFIC TUMOR ABLATION MARKET: INTERVIEW DEMOGRAPHICS 31
FIGURE 7 ASIA PACIFIC TUMOR ABLATION MARKET: MARKET END USERS COVERAGE GRID 34
FIGURE 8 ASIA PACIFIC TUMOR ABLATION MARKET: DBMR MARKET POSITION GRID 35
FIGURE 9 ASIA PACIFIC TUMOR ABLATION MARKET: VENDOR SHARE ANALYSIS 36
FIGURE 10 ASIA PACIFIC TUMOR ABLATION MARKET: SEGMENTATION 39
FIGURE 11 THE RISING PREVALENCE OF CANCER AND GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES ARE EXPECTED TO DRIVE THE GROWTH OF THE ASIA PACIFIC TUMOR ABLATION MARKET FROM 2023 TO 2030 40
FIGURE 12 THE THERMAL ABLATION SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC TUMOR ABLATION MARKET IN 2023 & 2030 40
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE ASIA PACIFIC TUMOR ABLATION MARKET 46
FIGURE 14 ASIA PACIFIC TUMOR ABLATION MARKET: BY TYPE, 2022 53
FIGURE 15 ASIA PACIFIC TUMOR ABLATION MARKET: BY TYPE, 2023-2030 (USD MILLION) 54
FIGURE 16 ASIA PACIFIC TUMOR ABLATION MARKET: BY TYPE, CAGR (2023-2030) 54
FIGURE 17 ASIA PACIFIC TUMOR ABLATION MARKET: BY TYPE, LIFELINE CURVE 55
FIGURE 18 ASIA PACIFIC TUMOR ABLATION MARKET: BY TYPES OF TREATMENT, 2022 62
FIGURE 19 ASIA PACIFIC TUMOR ABLATION MARKET: BY TYPES OF TREATMENT, 2023-2030 (USD MILLION) 63
FIGURE 20 ASIA PACIFIC TUMOR ABLATION MARKET: BY TYPES OF TREATMENT, CAGR (2023-2030) 63
FIGURE 21 ASIA PACIFIC TUMOR ABLATION MARKET: BY TYPES OF TREATMENT, LIFELINE CURVE 64
FIGURE 22 ASIA PACIFIC TUMOR ABLATION MARKET: BY CANCER TYPE, 2022 71
FIGURE 23 ASIA PACIFIC TUMOR ABLATION MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 72
FIGURE 24 ASIA PACIFIC TUMOR ABLATION MARKET: BY CANCER TYPE, CAGR (2023-2030) 72
FIGURE 25 ASIA PACIFIC TUMOR ABLATION MARKET: BY CANCER TYPE, LIFELINE CURVE 73
FIGURE 26 ASIA PACIFIC TUMOR ABLATION MARKET: BY END USERS, 2022 81
FIGURE 27 ASIA PACIFIC TUMOR ABLATION MARKET: BY END USERS, 2023-2030 (USD MILLION) 82
FIGURE 28 ASIA PACIFIC TUMOR ABLATION MARKET: BY END USERS, CAGR (2023-2030) 82
FIGURE 29 ASIA PACIFIC TUMOR ABLATION MARKET: BY END USERS, LIFELINE CURVE 83
FIGURE 30 ASIA PACIFIC TUMOR ABLATION MARKET: BY DISTRIBUTION CHANNEL, 2022 87
FIGURE 31 ASIA PACIFIC TUMOR ABLATION MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 88
FIGURE 32 ASIA PACIFIC TUMOR ABLATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 88
FIGURE 33 ASIA PACIFIC TUMOR ABLATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 89
FIGURE 34 ASIA-PACIFIC TUMOR ABLATION MARKET: SNAPSHOT (2022) 94
FIGURE 35 ASIA-PACIFIC TUMOR ABLATION MARKET: BY COUNTRY (2022) 95
FIGURE 36 ASIA-PACIFIC TUMOR ABLATION MARKET: BY COUNTRY (2023 & 2030) 95
FIGURE 37 ASIA-PACIFIC TUMOR ABLATION MARKET: BY COUNTRY (2022 & 2030) 96
FIGURE 38 ASIA-PACIFIC TUMOR ABLATION MARKET: BY TYPE (2023-2030) 96
FIGURE 39 ASIA PACIFIC TUMOR ABLATION MARKET: COMPANY SHARE 2022 (%) 154